Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68B Buy
4,784,982
+180,963
+4% +$64.5M 0.35% 50
2025
Q4
$1.51B Buy
4,604,019
+54,721
+1% +$17.4M 0.32% 53
2025
Q3
$1.28B Sell
4,549,298
-733,141
-14% -$213M 0.28% 68
2025
Q2
$1.47B Buy
5,282,439
+630,097
+14% +$179M 0.3% 61
2025
Q1
$1.45B Sell
4,652,342
-475,986
-9% -$141M 0.37% 49
2024
Q4
$1.34B Buy
5,128,328
+685,785
+15% +$203M 0.31% 52
2024
Q3
$1.43B Buy
4,442,543
+264,396
+6% +$86.5M 0.37% 42
2024
Q2
$1.31B Buy
4,178,147
+811,613
+24% +$238M 0.37% 43
2024
Q1
$957M Sell
3,366,534
-254,619
-7% -$74.5M 0.34% 54
2023
Q4
$1.04B Buy
3,621,153
+315,503
+10% +$86M 0.41% 42
2023
Q3
$888M Sell
3,305,650
-2,775
-0.1% -$693K 0.4% 41
2023
Q2
$800M Hold
3,308,425
0.39% 43
2023
Q1
$800M Buy
+3,308,425
New +$812M 0.39% 43
2022
Q4
Sell
-3,369,304
Closed -$759M 2553
2022
Q3
$759M Sell
3,369,304
-127,693
-4% -$31M 0.43% 38
2022
Q2
$851M Sell
3,496,997
-274,635
-7% -$67.3M 0.45% 37
2022
Q1
$912M Buy
3,771,632
+167,490
+5% +$38.5M 0.39% 44
2021
Q4
$811M Buy
3,604,142
+124,389
+4% +$26.3M 0.31% 62
2021
Q3
$740M Buy
3,479,753
+31,100
+0.9% +$7.16M 0.31% 60
2021
Q2
$841M Buy
3,448,653
+39,574
+1% +$9.74M 0.36% 55
2021
Q1
$848M Sell
3,409,079
-9,580
-0.3% -$2.29M 0.38% 49
2020
Q4
$786M Buy
3,418,659
+71,386
+2% +$16.5M 0.37% 48
2020
Q3
$851M Sell
3,347,273
-76,895
-2% -$19M 0.46% 38
2020
Q2
$808M Buy
3,424,168
+403,228
+13% +$92M 0.49% 33
2020
Q1
$612M Buy
3,020,940
+126,373
+4% +$27.6M 0.44% 42
2019
Q4
$698M Buy
2,894,567
+49,190
+2% +$10.8M 0.43% 44
2019
Q3
$551M Sell
2,845,377
-125,705
-4% -$24.1M 0.37% 52
2019
Q2
$548M Sell
2,971,082
-103,905
-3% -$18.6M 0.39% 48
2019
Q1
$584M Buy
3,074,987
+158,737
+5% +$30.3M 0.43% 42
2018
Q4
$568M Buy
2,916,250
+252,302
+9% +$49.2M 0.49% 37
2018
Q3
$552M Sell
2,663,948
-114,054
-4% -$22.5M 0.41% 42
2018
Q2
$513M Sell
2,778,002
-5,431
-0.2% -$961K 0.39% 45
2018
Q1
$475M Sell
2,783,433
-43,676
-2% -$8.02M 0.37% 50
2017
Q4
$492M Buy
2,827,109
+12,715
+0.5% +$2.25M 0.42% 45
2017
Q3
$525M Buy
2,814,394
+110,681
+4% +$19.6M 0.48% 42
2017
Q2
$466M Sell
2,703,713
-16,161
-0.6% -$2.63M 0.45% 41
2017
Q1
$446M Buy
2,719,874
+81,362
+3% +$13.5M 0.46% 42
2016
Q4
$386M Sell
2,638,512
-598,979
-19% -$90.1M 0.43% 44
2016
Q3
$540M Sell
3,237,491
-693,185
-18% -$117M 0.58% 28
2016
Q2
$598M Buy
3,930,676
+218,029
+6% +$33.9M 0.68% 22
2016
Q1
$557M Buy
3,712,647
+409,863
+12% +$60.9M 0.65% 23
2015
Q4
$536M Sell
3,302,784
-485,621
-13% -$76.3M 0.61% 25
2015
Q3
$524M Sell
3,788,405
-307,080
-7% -$48.4M 0.58% 32
2015
Q2
$629M Buy
4,095,485
+30,418
+0.7% +$4.87M 0.6% 31
2015
Q1
$650M Buy
4,065,067
+44,160
+1% +$6.95M 0.63% 24
2014
Q4
$640M Sell
4,020,907
-168,030
-4% -$26.2M 0.61% 28
2014
Q3
$588M Buy
4,188,937
+113,905
+3% +$14.9M 0.58% 33
2014
Q2
$482M Buy
4,075,032
+238,201
+6% +$27.6M 0.49% 42
2014
Q1
$473M Buy
3,836,831
+536,275
+16% +$65M 0.5% 37
2013
Q4
$377M Sell
3,300,556
-217,678
-6% -$24.8M 0.43% 50
2013
Q3
$394M Sell
3,518,234
-51,751
-1% -$5.61M 0.49% 40
2013
Q2
$352M Buy
+3,569,985
New +$370M 0.45% 46

Other funds holding AMGN

UBS AM's AMGN Position: Q1 2026 in Review

UBS AM increased its Amgen (AMGN) stake by 3.9% in Q1 2026, buying an estimated $64.5M and bringing the position to 4,784,982 shares worth $1.68B. The position accounts for 0.35% of the portfolio, ranked #50.

UBS AM first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • UBS AM held 4,784,982 shares of Amgen worth $1.68B as of Q1 2026.
  • UBS AM bought 180,963 Amgen shares in Q1 2026, an estimated $64.5M.
  • Amgen made up 0.35% of UBS AM's portfolio in Q1 2026, its #50 holding.
  • UBS AM first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.